Inhibition of NF-κB signaling has been shown to potentiate anti-CRC efficacy of 5-Fluorouracil (5-FU), the chemotherapeutic agent, or radiation [32,33,34]. This evidence concerns the gene NFKB1 and colorectal carcinoma.